The emergence of clinically abnormal levels of cardiovascular disease risk factor variables among young adults: the Bogalusa Heart Study

Preventive Medicine
W A WattigneyG S Berenson

Abstract

The Bogalusa Heart Study, a long-term epidemiologic investigation of the early natural history of atherosclerosis, was conducted for the first time in 1973-1974 on children from birth through the age of 14 in a biracial (black-white) population. The emergence of clinically recognizable abnormalities (obesity, hypertension, and hyperlipidemia) was studied in 1,928 young adults, ages 19-32 years, examined in the 1988-1991 survey. The occurrence of morbid levels of cardiovascular disease risk factors varied by race and gender. The prevalence of severe overweight, body mass index > or = 31.1 kg/m2 for males and > or = 32.3 kg/m2 for females, was much higher for black women (20.1% than for white women (8.7%), black men (14.0%), or white men (11.7%). The frequency of hypertension [systolic blood pressure (BP) > or = 140 mm Hg, diastolic BP > or = 90 mm Hg, or treatment for high BP] was greatest for black women (13.9%) versus black men (10.1%), white men (6.2%), or white women (5.0%). Approximately 9.5% of the men and 6% of the women had elevated LDL cholesterol ( > or = 160 mg/dl), while elevated triglycerides ( > or = 250 mg/dl ranged from 0% in black females to 7.4% in white males. Dyslipoproteinemia related to HDL cholesterol ( < ...Continue Reading

Associated Clinical Trials

May 26, 2000·Lydia A. Bazzano

Citations

Aug 18, 2000·The Proceedings of the Nutrition Society·M B Livingstone, P J Robson
Dec 1, 1995·The American Journal of the Medical Sciences·G S BerensonB Radhakrishnamurthy
Mar 1, 2008·Journal of the American Society of Hypertension : JASH·Gerald S BerensonWei Chen
Dec 22, 1998·The American Journal of Cardiology·G S BerensonT A Nicklas
Nov 5, 2014·PloS One·Vivian T W PoonChris I Ardern
Sep 8, 2009·The Journal of Pediatrics·Stephen CookTerry T-K Huang
Oct 23, 2004·Journal of the American Dietetic Association·Debby Demory-LuceGerald Berenson
Apr 30, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Teresa Flores-DorantesSamuel Canizales-Quinteros
Nov 22, 2008·American Journal of Hypertension·Charmaine S WrightEmily Oken
Mar 11, 2016·Orthopaedic Journal of Sports Medicine·Eric C StiefelFelix H Savoie
Jan 31, 2018·Medicine and Science in Sports and Exercise·Huimin YanRobert C Hickner
Mar 6, 2002·Circulation·Qing HeDympna Gallagher
Apr 19, 2002·Paediatric Drugs·Deepak Bhatnagar
Jun 15, 2016·Journal of Paediatrics and Child Health·Angela Therese Titmuss, Shubha Srinivasan
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·Nicole Cossrow, Bonita Falkner
Dec 17, 2014·Journal of Pediatric Endocrinology & Metabolism : JPEM·Ahmet OzturkSelim Kurtoglu
Nov 21, 2008·Expert Review of Cardiovascular Therapy·Keith C Ferdinand, Daphne P Ferdinand
Mar 21, 1998·The Journal of Nutrition·W H Dietz
Dec 31, 1997·The American Journal of the Medical Sciences·C E O'NeilG S Berenson
Aug 20, 2010·Diabetology & Metabolic Syndrome·Alfredo HalpernMarcia Nery

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.